Background illustration for clinical trials search

Paid Clinical Trials Olathe

Discover 707 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

for
Narcolepsy Type 1
Location: Kansas City KS, St Louis MO, Madison WI, Cullman AL,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07455383

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

for
Narcolepsy Type 2
Location: Kansas City KS, Frisco TX, Cullman AL, Boulder CO,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07502443

Phase3, Recruiting

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

for
Asthma
Location: Kansas City KS, St Louis MO, London, DuBois PA, Ajax,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06979323

Phase3, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Kansas City KS, Lincoln NE, Peoria IL, Little Rock AR,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase2, Phase3, Recruiting

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

for
Parkinson Disease
Location: Kansas City KS, Chesterfield MO, Chicago IL, Aurora CO,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 40 - 70+

Code: NCT06976268

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Kansas City KS, Springfield MO, Wichita KS, Omaha NE,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

for
Ulcerative Colitis, Crohn's Disease
Location: Kansas City MO, Columbia MO, Hutchinson KS,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06581328

Recruiting

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Kansas City MO, Wichita KS, Tulsa OK, Jacksonville FL,
Sponsor: Edwards Lifesciences

Sex: All

Age: 65+

Code: NCT04889872

Recruiting

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

for
B-cell Acute Lymphoblastic Leukemia, Obesity
Location: Kansas City KS, Minneapolis MN, Chicago IL, Dallas TX,
Sponsor: Etan Orgel

Sex: All

Age: 7 - 25

Code: NCT05082519

Phase2, Recruiting

Continuous Monitoring and Control of Hypoglycemia

for
Diabetes
Location: Kansas City MO, Topeka KS, Oklahoma City OK,
Sponsor: DexCom, Inc.

Sex: All

Age: 2+

Code: NCT03340831

Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

for
Atypical Teratoid/Rhabdoid Tumor,
Location: Kansas City KS, St Louis MO, Little Rock AR, Dallas TX,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 26

Code: NCT06465199

Phase1, Phase2, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Kansas City MO, Wichita KS, Omaha NE, Des Moines IA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Kansas City MO, Columbia MO, Wichita KS, Omaha NE,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Kansas City MO, Wichita KS, Omaha NE, Des Moines IA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for
Childhood Extracranial Germ Cell Tumor,
Location: Kansas City MO, Osage Beach MO, Columbia MO, Creston IA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase3, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Kansas City MO, Columbia MO, Wichita KS, Bellevue NE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Kansas City MO, Columbia MO, Wichita KS, Omaha NE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase3, Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Kansas City MO, Columbia MO, Wichita KS, Omaha NE,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Kansas City MO, Saint Joseph MO, Bolivar MO,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Kansas City MO, Topeka KS, Bridgeton MO, O'Fallon IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting